The MEK1/2 Inhibitor Pimasertib Enhances Gemcitabine...

The MEK1/2 Inhibitor Pimasertib Enhances Gemcitabine Efficacy in Pancreatic Cancer Models by Altering Ribonucleotide Reductase Subunit-1 (RRM1)

Vena, F., Li Causi, E., Rodriguez-Justo, M., Goodstal, S., Hagemann, T., Hartley, J. A., Hochhauser, D.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
21
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.ccr-15-0485
Date:
December, 2015
File:
PDF, 3.16 MB
english, 2015
Conversion to is in progress
Conversion to is failed